4,881 followers
@genomerambler that leads to a better bioavailability and stability, resulting in better results - refer to https://t.co/5O8YWUnMJ3
@genomerambler that leads to a better bioavailability and stability, resulting in better results - refer to https://t.co/5O8YWUnMJ3
SUTAIN3 セマグルチド1mgと週1回エキセナチド2mgの比較 https://t.co/4vyJwLGk2l
RT @mangascruz: Clara superioridad de #semaglutida versus #bydureon, en HbA1c (1.5 vs 0.9%) y peso, pero con peor tolerabilidad digestiva.…
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial https://t.co/HVXNNhMh61